223 related articles for article (PubMed ID: 30598028)
1. Design and Synthesis of C-19 Isosteviol Derivatives as Potent and Highly Selective Antiproliferative Agents.
Luan T; Cao LH; Deng H; Shen QK; Tian YS; Quan ZS
Molecules; 2018 Dec; 24(1):. PubMed ID: 30598028
[TBL] [Abstract][Full Text] [Related]
2. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, cytotoxic activity evaluation and HQSAR study of novel isosteviol derivatives as potential anticancer agents.
Liu CJ; Yu SL; Liu YP; Dai XJ; Wu Y; Li RJ; Tao JC
Eur J Med Chem; 2016 Jun; 115():26-40. PubMed ID: 26994841
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxic activity, and 2D- and 3D-QSAR studies of 19-carboxyl-modified novel isosteviol derivatives as potential anticancer agents.
Liu CJ; Zhang T; Yu SL; Dai XJ; Wu Y; Tao JC
Chem Biol Drug Des; 2017 Jun; 89(6):870-887. PubMed ID: 27878967
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
8. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol.
Malki A; Laha R; Bergmeier SC
Bioorg Med Chem Lett; 2014 Feb; 24(4):1184-7. PubMed ID: 24444475
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives.
Li D; Han T; Hu X; Tian K; Xu S; Zhou T; Cheng K; Li Z; Hua H; Xu J
Anticancer Agents Med Chem; 2017; 17(12):1679-1688. PubMed ID: 28403782
[TBL] [Abstract][Full Text] [Related]
11. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
[TBL] [Abstract][Full Text] [Related]
12. Syntheses, cytotoxic activity evaluation and HQSAR study of 1,2,3-triazole-linked isosteviol derivatives as potential anticancer agents.
Liu CJ; Liu YP; Yu SL; Dai XJ; Zhang T; Tao JC
Bioorg Med Chem Lett; 2016 Nov; 26(22):5455-5461. PubMed ID: 27777008
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of glaucocalyxin A derivatives as potential anticancer agents.
Yang J; Liu Y; Xue C; Yu W; Zhang J; Qiao C
Eur J Med Chem; 2014 Oct; 86():235-41. PubMed ID: 25164762
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
Shen QK; Deng H; Wang SB; Tian YS; Quan ZS
Eur J Med Chem; 2019 Jul; 173():15-31. PubMed ID: 30981113
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
Khaybullin RN; Liang X; Cisneros K; Qi X
Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
[TBL] [Abstract][Full Text] [Related]
18. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
19. Antitumor Activities of the Novel Isosteviol Derivative 10C Against Liver Cancer.
Malki A; El-Sharkawy A; El Syaed M; Bergmeier S
Anticancer Res; 2017 Apr; 37(4):1591-1601. PubMed ID: 28373419
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
Wang TT; Liu Y; Chen L
Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
